Background: The 2-amino 1,3,4-thiadiazole framework has attracted considerable interest because of its prevalence in compounds possessing a wide range of pharmacological properties including anticancer/antitumor activities. Though a number of methods have been reported for the synthesis of this class of compounds, some of them are not straightforward, inexpensive and environmentally friendly.
Objective: To synthesize 2-amino-1,3,4-thiadiazole derivatives that could act as potential anticancer agents.
Methods: The use of lemon juice as an inexpensive and readily available biocatalyst was explored in the synthesis of 2-amino 1,3,4-thiadiazole derivatives. Accordingly, a convenient method has been developed for the rapid synthesis of this class of compounds under a mild and non-hazardous reaction condition in good yields. The methodology involved the reaction of various acid hydrazides with TMSNCS in the presence of lemon juice in PEG-400 at room temperature (25-30ºC) under ultrasound irradiation. These compounds were assessed for their cytotoxic properties against two different metastatic breast cancer cell lines e.g., MDAMB-231 and MCF-7 and subsequently against SIRT1.
Results: The 2-amino 1,3,4-thiadiazole derivatives 3a, 3i, 3j and 3l showed promising growth inhibition of MDAMB- 231 and MCF-7 cell lines and SIRT1 inhibition in vitro. Indeed, 3i was found to be a potent inhibitor of SIRT1.
Conclusion: An ultrasound-assisted method facilitated by lemon juice has been developed to synthesize 2-amino- 1,3,4-thiadiazole derivatives that could act as potential anticancer agents.
[http://dx.doi.org/10.1016/j.bmc.2005.10.064] [PMID: 16310359]
[http://dx.doi.org/10.1007/BF00195367] [PMID: 3170135]
(b)Nelson, J.A.; Rose, L.M.; Bennett, L.L., Jr Mechanism of action of 2-amino-1,3,4-thiadiazole (NSC 4728). Cancer Res., 1977, 37(1), 182-187.
(c)Asbury, R.F.; Blessing, J.A.; McGuire, W.P.; Hanjani, P.; Mortel, R. Aminothiadiazole (NSC 4728) in patients with advanced carcinoma of the endometrium. A phase II study of the Gynecologic Oncology group. Am. J. Clin. Oncol., 1990, 13(1), 39-41.
[http://dx.doi.org/10.1097/00000421-199002000-00011] [PMID: 2407103]
[http://dx.doi.org/10.1016/j.bmc.2007.02.041] [PMID: 17350846]
(b)Matysiak, J.; Opolski, A. Synthesis and antiproliferative activity of N-substituted 2-amino-5-(2,4-dihydroxyphenyl)-1,3,4- thiadiazoles. Bioorg. Med. Chem., 2006, 14(13), 4483-4489.
[http://dx.doi.org/10.1016/j.bmc.2006.02.027] [PMID: 16517170]
(c)Nelson, J.A.; Rose, L.M.; Bennett, L.L. Effects of 2-amino-1,3,4-thiadiazole on ribonucleotide pools of leukemia L1210 cells. Cancer Res., 1976, 36(4), 1375-1378.
[http://dx.doi.org/10.1016/j.bmcl.2011.08.022] [PMID: 21875796]
[http://dx.doi.org/10.1016/j.bmc.2003.10.041] [PMID: 14738972]
[http://dx.doi.org/10.1016/j.bmcl.2012.07.036] [PMID: 22877634]
[http://dx.doi.org/10.1016/j.bmcl.2014.05.028] [PMID: 24880902]
[http://dx.doi.org/10.1016/j.ccr.2008.03.004] [PMID: 18455128]
[http://dx.doi.org/10.1038/sj.onc.1209049] [PMID: 16170353]
[http://dx.doi.org/10.1158/1535-7163.MCT-09-0971] [PMID: 20371709]
[http://dx.doi.org/10.1016/j.bbrc.2017.05.089] [PMID: 28526414]
[http://dx.doi.org/10.1039/c3cc42840k] [PMID: 23732749]
[http://dx.doi.org/10.1016/S0968-0896(02)00143-8] [PMID: 12110309]
[http://dx.doi.org/10.1016/j.ejmech.2008.01.039] [PMID: 18395299]
[http://dx.doi.org/10.1038/nature06261] [PMID: 18046409]